Bio Essence Corporation
BIOE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $137 | $259 | $22 | $148 |
| % Growth | -47.2% | 1,067.8% | -85% | – |
| Cost of Goods Sold | $41 | $90 | $2 | $41 |
| Gross Profit | $96 | $169 | $21 | $107 |
| % Margin | 70% | 65.1% | 92.8% | 72.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $81 | $107 | $225 | $103 |
| SG&A Expenses | $82 | $107 | $226 | $103 |
| Sales & Mktg Exp. | $1 | $0 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $82 | $107 | $226 | $103 |
| Operating Income | $14 | $61 | -$205 | $4 |
| % Margin | 10.4% | 23.6% | -924.3% | 2.6% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$31 |
| Pre-Tax Income | $13 | $61 | -$206 | -$28 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | $13 | $60 | -$206 | -$28 |
| % Margin | 9.5% | 23.1% | -927.3% | -18.7% |
| EPS | 0 | 0.002 | -0.005 | -0.001 |
| % Growth | -81.3% | 129.6% | -671.4% | – |
| EPS Diluted | 0 | 0.002 | -0.005 | -0.001 |
| Weighted Avg Shares Out | 38,009 | 38,009 | 38,009 | 38,009 |
| Weighted Avg Shares Out Dil | 38,009 | 38,009 | 38,009 | 38,009 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $14 | $61 | -$205 | -$27 |
| % Margin | 10% | 23.6% | -924.3% | -18.1% |